Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Humana and The Humana Foundation Offer Support to Those Affected by Tornados
Humana and The Humana Foundation Offer Support to Those Affected by Tornados


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, launched a series of efforts to assist its members, employees and communities in the Midwest and southern part

Fifth Third Bancorp Announces Cash Dividends
Fifth Third Bancorp Announces Cash Dividends


Today Fifth Third Bancorp announced the declaration of cash dividends on its common shares, Series H preferred shares, Series I preferred shares, Series J preferred shares, Series K preferred

Fifth Third Bancorp Announces Cash Dividends
Fifth Third Bancorp Announces Cash Dividends


Today Fifth Third Bancorp announced the declaration of cash dividends on its common shares, Series H preferred shares, Series I preferred shares, Series J preferred shares, Series K preferred

Acadia Healthcare Forms Joint Venture With SCL Health to Build a New Behavioral Health Facility in Denver Metro Area
Acadia Healthcare Forms Joint Venture With SCL Health to Build a New Behavioral Health Facility in Denver Metro Area


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with SCL Health, one of Colorado’s premier healthcare systems. The new partnership will build a new

DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences


Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual

Brazil Leaps into Data Analytics with Notable Projects, But Broad Adoption Still in Early Stages
Brazil Leaps into Data Analytics with Notable Projects, But Broad Adoption Still in Early Stages


Brazilian enterprises prioritized digital transformation in 2021 in response to the COVID-19 pandemic, in some cases implementing remarkable uses of data science to better serve customers and

Willdan Awarded $90 Million Contract to Reduce Greenhouse Gas Emissions in New York Housing
Willdan Awarded $90 Million Contract to Reduce Greenhouse Gas Emissions in New York Housing


Willdan Group, Inc. (NASDAQ: WLDN) announced today that New York City Housing Authority (NYCHA) selected Willdan through a technical engineering competition to provide innovative thermal load

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
CI Global Asset Management Announces December 2021 Distributions for CI ETFs
CI Global Asset Management Announces December 2021 Distributions for CI ETFs


CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending December 31, 2021 in respect of CI ETFs. In all cases, the distribution will

Gold Standard Diagnostics, ein Unternehmen von Eurofins Technologies, bringt neuen CE-zertifizierten Assay für den Nachweis der Omikron-Variante von SARS-CoV-2 auf den Markt
Gold Standard Diagnostics, ein Unternehmen von Eurofins Technologies, bringt neuen CE-zertifizierten Assay für den Nachweis der Omikron-Variante von SARS-CoV-2 auf den Markt


Gold Standard Diagnostics setzt sich weiter im Kampf gegen die sich ausbreitende Omikron-Variante von SARS-CoV-2 ein, indem es innovative Diagnostiklösungen an die Hand gibt.



Die Omikron-Variante

Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death


Pfizer Inc. (NYSE: PFE) today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients)

Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death


Pfizer Inc. (NYSE: PFE) today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients)

Gold Standard Diagnostics, a Eurofins Technologies Company, Launches CE Marked Assay for the Detection of the Omicron SARS-CoV-2 Variant
Gold Standard Diagnostics, a Eurofins Technologies Company, Launches CE Marked Assay for the Detection of the Omicron SARS-CoV-2 Variant


Gold Standard Diagnostics continues its response to the threat of the emerging Omicron SARS-CoV-2 variant by providing innovative diagnostic solutions.



The Omicron SARS-CoV-2 variant has raised

DGAP-News: Deutsche Wohnen SE:  Deutsche Wohnen beantragt Wechsel in den General Standard des regulierten Marktes der Deutschen Börse
DGAP-News: Deutsche Wohnen SE: Deutsche Wohnen beantragt Wechsel in den General Standard des regulierten Marktes der Deutschen Börse
DGAP-News: Deutsche Wohnen SE: Deutsche Wohnen beantragt Wechsel in den General Standard des regulierten Marktes der Deutschen Börse
DGAP-News: Deutsche Wohnen SE:  Deutsche Wohnen applies for change of segment to General Standard on the regulated market of the Frankfurt Stock Exchange
DGAP-News: Deutsche Wohnen SE: Deutsche Wohnen applies for change of segment to General Standard on the regulated market of the Frankfurt Stock Exchange
DGAP-News: Deutsche Wohnen SE: Deutsche Wohnen applies for change of segment to General Standard on the regulated market of the Frankfurt Stock Exchange
AIXTRON sagt YESvGaN / Epitaxie-Spezialist AIXTRON ist Partner im EU-Forschungsprojekt YESvGaN / Hohe Energieeffizienz und niedrige CO2-Emissionen durch GaN-Leistungstransistoren
AIXTRON sagt YESvGaN / Epitaxie-Spezialist AIXTRON ist Partner im EU-Forschungsprojekt YESvGaN / Hohe Energieeffizienz und niedrige CO2-Emissionen durch GaN-Leistungstransistoren
AIXTRON sagt YESvGaN / Epitaxie-Spezialist AIXTRON ist Partner im EU-Forschungsprojekt YESvGaN / Hohe Energieeffizienz und niedrige CO2-Emissionen durch GaN-Leistungstransistoren
AIXTRON says YESvGaN / Epitaxy specialist AIXTRON is partner of EU research project YESvGaN / High energy efficiency and low CO2 emissions by using GaN power transistors
AIXTRON says YESvGaN / Epitaxy specialist AIXTRON is partner of EU research project YESvGaN / High energy efficiency and low CO2 emissions by using GaN power transistors
AIXTRON says YESvGaN / Epitaxy specialist AIXTRON is partner of EU research project YESvGaN / High energy efficiency and low CO2 emissions by using GaN power transistors
AIXTRON sagt YESvGaN / Epitaxie-Spezialist AIXTRON ist Partner im EU-Forschungsprojekt YESvGaN / Hohe Energieeffizienz und niedrige CO2-Emissionen durch GaN-Leistungstransistoren
AIXTRON sagt YESvGaN / Epitaxie-Spezialist AIXTRON ist Partner im EU-Forschungsprojekt YESvGaN / Hohe Energieeffizienz und niedrige CO2-Emissionen durch GaN-Leistungstransistoren
AIXTRON sagt YESvGaN / Epitaxie-Spezialist AIXTRON ist Partner im EU-Forschungsprojekt YESvGaN / Hohe Energieeffizienz und niedrige CO2-Emissionen durch GaN-Leistungstransistoren
AIXTRON says YESvGaN / Epitaxy specialist AIXTRON is partner of EU research project YESvGaN / High energy efficiency and low CO2 emissions by using GaN power transistors
AIXTRON says YESvGaN / Epitaxy specialist AIXTRON is partner of EU research project YESvGaN / High energy efficiency and low CO2 emissions by using GaN power transistors
AIXTRON says YESvGaN / Epitaxy specialist AIXTRON is partner of EU research project YESvGaN / High energy efficiency and low CO2 emissions by using GaN power transistors
DGAP-News: Vossloh Aktiengesellschaft: Vossloh gewinnt erneut Großauftrag für Schienenbefestigungssysteme in China
DGAP-News: Vossloh Aktiengesellschaft: Vossloh gewinnt erneut Großauftrag für Schienenbefestigungssysteme in China
DGAP-News: Vossloh Aktiengesellschaft: Vossloh gewinnt erneut Großauftrag für Schienenbefestigungssysteme in China
DGAP-News: Vossloh Aktiengesellschaft: Vossloh wins another major order from China for rail fastening systems
DGAP-News: Vossloh Aktiengesellschaft: Vossloh wins another major order from China for rail fastening systems
DGAP-News: Vossloh Aktiengesellschaft: Vossloh wins another major order from China for rail fastening systems
EQS-News: Global insured catastrophe losses rise to USD 112 billion in 2021, the fourth highest on record, Swiss Re Institute estimates
EQS-News: Global insured catastrophe losses rise to USD 112 billion in 2021, the fourth highest on record, Swiss Re Institute estimates
EQS-News: Global insured catastrophe losses rise to USD 112 billion in 2021, the fourth highest on record, Swiss Re Institute estimates